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Pregnancies  complicated  by  preeclampsia  (PE)  are  characterised  by  an  enhanced  maternal  and  fetal
inﬂammatory  response  with  increased  numbers  of  leukocytes  in maternal  peripheral  blood.  The  impact
of PE  on newborn  umbilical  cord  blood  cell  (UCBC)  populations  however,  has  been  scarcely  studied.  We
hypothesise  that  PE  deranges  fetal haematopoiesis  and  subsequently  UCBC  populations.  Therefore,  the
objective  of this  study  was  to investigate  newborn  umbilical  cord  blood  cell  populations  in early-  (EOPE)
and  late-onset  PE  (LOPE).
A  secondary  cohort  analysis  in  The  Rotterdam  Periconceptional  Cohort  was  conducted  comprising  23 PE
cases,  including  11  EOPE  and  12 LOPE,  and  195  controls,  including  153  uncomplicated  and  23  fetal  growth
restriction-  and  19  preterm  birth  complicated  controls.  UCBC  counts  and  differentials  were  quantiﬁed  by
ﬂow  cytometry  and  analysed  as main  outcome  measures.
Multivariable  regression  analysis  revealed  associations  of EOPE  with  decreased  leucocyte-  (monocytes,
neutrophils,  eosinophils,  immature  granulocytes)  and thrombocyte  counts  and increased  NRBC  counts
(all p  < 0.05).  EOPE  remained  associated  with  neutrophil-  (-0.92,  95%CI  −1.27,−0.57,  p  < 0.001)  and  NRBC
counts  (1.11,  95%CI  0.27,1.95,  p = 0.010)  after  adjustment  for  gestational  age  and  birth  weight.  LOPE  did
not reveal  any  signiﬁcant  association.
We conclude  that  derangements  of fetal  haematopoiesis,  in particular  of  neutrophil-  and  NRBC  counts,
are associated  with  EOPE  only,  with  a potential  impact  for  future  health  of the  offspring.  This  het-
erogeneity  in  UCBC  should  be considered  as confounder  in  epigenetic  association  studies  examining
EOPE.
©  2016  Elsevier  Ireland  Ltd.  All  rights  reserved.Abbreviations: PE, preeclampsia; EOPE, early- onset preeclampsia; LOPE, late-
nset preeclampsia; FGR, fetal growth restriction; PTB, preterm birth; BMI, body
ass index; UCB, umbilical cord blood; UCBC, umbilical cord blood cell; NRBC,
ucleated red blood cell; CI, conﬁdence interval.
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Preeclampsia (PE) is a heterogeneous disease with early-onset
(EOPE) and late-onset (LOPE) PE as the main phenotypes.
Due to inadequate spiral artery remodelling with suboptimal
placental perfusion, excessive amounts of oxidative stress can
lead to an enhanced release of syncytiotrophoblast microparticles
and cytokines, which particularly contributes to the pathogene-
sis of the more severe EOPE phenotype (Raymond and Peterson,
2011). In contrast, LOPE shows a relatively normal initial placen-
tation and is associated with conditions that enhance excessive
oxidative stress and placental inﬂammation later in pregnancy,
such as obesity and pre-existing hypertension (Burton et al., 2009;
8 oducti
S
t
r
c
e
(
l
c
s
R
e
r
I
c
2
p
b
S
T
r
c
o
p
t
w
i
o
S
a
r
g
d
a
c
t
i
p
p
L
t
w
w
d
P
c
p
t
i
e
n
r
p
c
M
2
w
a2 E.M. Herzog et al. / Journal of Repr
teegers et al., 2010). Circulating syncytiotrophoblast micropar-
icles can induce an increased maternal systemic inﬂammatory
esponse with increased numbers of neutrophils and total leuko-
ytes in maternal peripheral blood (Canzoneri et al., 2009; Lurie
t al., 1998). The impact of PE on newborn umbilical cord blood cell
UCBC) populations, however, has been scarcely studied.
During pregnancy, haematopoiesis takes place in the yolk sac,
iver, bone marrow as well as in the placenta, generating all blood
ell types from a small population of pluripotent hematopoietic
tem cells as pregnancy advances (Davies et al., 1992; Dzierzak and
obin, 2010; Morrison et al., 1995; Proytcheva, 2009). We  hypoth-
sise that PE, in particular EOPE, deranges fetal haematopoiesis
esulting in heterogeneity of UCBC populations (Sashida and
wama, 2012), and investigated the associations between UCBC
ounts and differentials in early- and late-onset PE.
. Materials and methods
Study design Between June 2011 and June 2013 we  included
regnant women in a prospective hospital-based periconceptional
irth cohort: The Rotterdam Periconceptional Cohort (Predict
tudy), at the Erasmus MC,  University Medical Centre Rotterdam,
he Netherlands (Steegers-Theunissen et al., 2015). For the cur-
ent secondary cohort analysis, we selected EOPE and LOPE as
ases and uncomplicated pregnancies as controls. To adjust for the
ften accompanied fetal growth restriction (FGR) and iatrogenic
reterm birth (PTB) in PE, we oversampled the uncomplicated con-
rol group with FGR and PTB as complicated controls. Pregnancies
ere included in the cohort during the ﬁrst trimester (early cohort
nclusions) or after the ﬁrst trimester when they were referred to
ur hospital (late cohort inclusions).
PE was deﬁned according to the International Society for the
tudy of Hypertension in Pregnancy as gestational hypertension of
t least 140/90 mmHg  accompanied by an urine protein/creatinine
atio of ≥30 mg/mmol, arising de novo after the 20th week of
estation (Brown et al., 2001). EOPE was deﬁned when PE was
iagnosed before 34 weeks of gestation, LOPE when diagnosed
fter 34 weeks of gestation (Tranquilli et al., 2013). Uncompli-
ated control pregnancies were deﬁned as pregnancies without
he presence of PE, gestational hypertension, FGR or PTB. FGR
nclusion was based on an estimated fetal weight below the 10th
ercentile for gestational age based on ultrasound measurements
erformed between 20 and 38 weeks of gestation (Battaglia and
ubchenco, 1967). Birth weight percentiles were calculated using
he reference curves of the Dutch Perinatal Registry to validate birth
eight ≤10th percentile and exclude those newborns with birth
eight >10th percentile (Visser et al., 2009). Spontaneous preterm
eliveries between 22 and 37 weeks of gestation were deﬁned as
TB (2013). Women  with HIV infection, age <18 years and insufﬁ-
ient knowledge of the Dutch language could not participate and
regnancies complicated with a fetal congenital malformation and
wins were excluded for the current study. Maternal comorbid-
ty was deﬁned by any concurrent cardiovascular-, heamatologic-,
ndocrine-, metabolic-, auto-immune- or renal disease. Mater-
al and fetal characteristics were obtained from hospital medical
ecords. All women gave written informed consent before partici-
ation and written parental informed consent was obtained for the
hild. Ethical approval was given by the Erasmus MC, University
edical Centre Research Ethics Board (MEC-2004-227).
.1. Collection and handling of blood samplesUmbilical cord blood (UCB) samples from the umbilical vein
ere obtained in vacutainer tubes (Ethylenediaminetetraacetic
cid as anticoagulant), immediately after delivery and clamping ofve Immunology 116 (2016) 81–85
the umbilical cord. Samples were transported at room temperature
and subjected to ﬂow cytometric analysis within 48 h after delivery
(Sysmex XE-5000, Sysmex XN-3000 and XS-800i, Etten-Leur, The
Netherlands) to quantify erythrocytes, thrombocytes and leucocyte
differentials. Between arrival at the Clinical Chemistry Laboratory
and time of analysis, samples were stored at 4–8 ◦C. Quality of the
blood cell counts was  guaranteed by a manual check whereby ﬂow
cytometric data of suspect plots or reported system errors were
excluded for further analysis.
2.2. Statistical analysis
We  used cell numbers/L for the analysis of leucocyte differen-
tials and nucleated red blood cells (NRBC), which is preferable to
the widely used percentages of total leucocyte count, since the
largely variable total leucocyte count could result in misleading
percentages (Perrone et al., 2005). The normal distributed maternal
and newborn characteristics were tested using Analysis of Vari-
ance (ANOVA) to detect overall differences between the groups,
followed by the posthoc Dunnett t-test for pairwise comparisons
of EOPE and LOPE with uncomplicated controls and FGR and PTB
complicated controls. The Dunnett t-test limits the multiple testing
problem by comparing each group to one reference group only. The
Kruskall-Wallis-test was applied to all non-parametric maternal
and newborn characteristics, followed by pairwise Mann-Whitney
tests for posthoc comparisons.
Log-transformation was  applied to the non-parametric UCBC
to achieve normal distributions of neutrophils, monocytes,
eosinophils, basophils, NRBC and immature granulocytes. We  con-
verted zero values of neutrophils and NRBC into half of the lowest
detectable value of the Sysmex haematology system, prior to
log-transformation. Linear regression analysis was performed to
investigate the association between UCBC counts and differentials
and EOPE/LOPE versus the pooled group of (un)complicated con-
trols. In the crude linear regression analyses, UCBC counts were
estimated with group (case-control) as the only predictive vari-
able. In the adjusted multivariable analyses, gestational age and
birth weight were additionally entered to the model as covariates,
in formula: [UCBC] = 0 + 1group + 2GA + 3BW + . Here group
is an indicator variable that is 1 for EOPE or LOPE and 0 for the
pooled group of (un)complicated controls. [UCBC] represents the
concentration of a certain UCBC population. All measurements
were performed with IBM SPSS Statistics version 21.0 (SPSS Inc,
Chicago, IL, USA).
3. Results
From the Predict Study we included all eligible women for
this secondary cohort analysis that met  the inclusion criteria as
described earlier (n = 412). After exclusion of 194 pregnancies
due to missing blood samples (n = 117) or poor quality of blood
cell counts (n = 77), 218 pregnancies were included for analysis.
Patients with missing data were characterised by a shorter ges-
tational age (38.2 versus 39.1 weeks, p < 0.001) and lower birth
weight (3065 versus 3363 g, p < 0.001) as compared to the ﬁnal
study population, and contained twice as much EOPE- (10.3%
versus 5.0%) and LOPE pregnancies (9.3% versus 5.5%, p = 0.076),
as depicted in Supplemental Table 1. The ﬁnal study population
comprised 23 cases of PE including 11 EOPE and 12 LOPE, and 195
controls, including 153 uncomplicated controls and 23 FGR and 19
PTB complicated controls (Supplemental Fig. 1).Maternal and newborn characteristics are shown in Table 1. In
addition to the case speciﬁc parameters blood pressure, protein-
uria, gestational age and birth weight, a signiﬁcant lower mean
maternal age in EOPE versus LOPE and uncomplicated controls was
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Table  1
Maternal and newborn characteristics.
Maternal characteristics Uncomplicated Complicated controls
EOPE LOPE controls FGR PTB Overall
(n  = 11) (n = 12) (n = 153) (n = 23) (n = 19) p-value
Age (years) 27.1 (5.2) 34.1* (3.8) 32.2* (5.1) 29.3,** (5.8) 30.6 (5.2) 0.002
Nulliparous, n (%) 8 (72.7) 7 (58.3) 66 (43.1) 11 (47.8) 6 (31.3) 0.204
Ethnicity, n (%) Western
Non-Western
9 (81.8)
1 (18.2)
7 (58.3)
5 (41.7)
122 (80.3)
30 (19.7)
14 (60.9)
9 (39.1)
15 (83.3)
3 (16.7)
0.152
Preconception BMIa (kg/m2) 26.8 (9.3) 26.4 (2.8) 24.1 (7.1) 23.6 (5.6) 24.1 (7.1) 0.785
Smoking during pregnancy (yes), n (%) 1 (12.5) 0 (0.0) 8 (5.4) 2 (9.1) 1 (6.3) 0.813
Co-morbidity (yes), n (%) 1 (9.1) 3 (25.0) 61 (39.9) 4 (17.4) 3 (15.8) 0.022
Newborn characteristics
Male gender, n (%) 9 (81.8) 7 (58.3) 77 (50.3) 14 (60.9) 9 (47.4) 0.210
Gestational age at birtha (weeks) 31.0 (3.7) 37.4* (1.9) 39.6*,** (1.7) 39.0*,** (2.6) 35.9*,** (4.9) <0.001
Birth  weighta (grams) 1155 (353) 3238* (1689) 3515* (563) 2625*,** (600) 2650*,** (1455) <0.001
Birth  weight <10th percentile, n (%) 2 (18.2) 2 (16.7) 0*,** (0.0) 23*,** (100.0) 0 (0.0) <0.001
Data are presented as mean (standard deviation) with corresponding ANOVA testing to examine overall differences between the groups, followed by the post hoc Dunnett
t-test  for pairwise comparisons of EOPE and LOPE with (un)complicated controls.
Data are presented as number (%) with corresponding Chi2/Fischer’s exact testing.
ANOVA analysis of variance; BMI  body mass index; EOPE early onset preeclampsia; LOPE late onset preeclampsia; FGR fetal growth restriction; PTB preterm birth.
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* p < 0.05 versus EOPE pregnancies.
** p < 0.05 versus LOPE pregnancies.
hown (27.1 year, versus 34.1 and 32.2 year respectively, overall
 = 0.002). EOPE pregnancies ended more often in a caesarean sec-
ion compared to LOPE and (un)complicated controls (90%, versus
5% and up to 35% respectively, overall p = 0.003). Comorbidity was
igniﬁcantly different between the groups and highest in uncom-
licated controls, but no signiﬁcant differences were observed in
he posthoc analysis. Neonatal temperature at birth was  similar for
ach group.
By ANOVA testing, we observed signiﬁcantly lower cell counts
or all UCBC populations and a signiﬁcantly higher NRBC count in
OPE versus (un)complicated controls. In LOPE only signiﬁcantly
igher neutrophil- and erythrocyte counts and lower reticulocyte
ounts compared to PTB complicated controls were observed (Sup-
lemental Table S2).
In Table 2 we show the results of the linear regression analyses
f the UCBC counts and differentials of both EOPE and LOPE versus
he pooled (un)complicated controls. The crude estimates revealed
hat EOPE was associated with the decreased counts of total leu-
ocytes ( −7.6, 95% CI −10.53, −4.76, p < 0.001); monocytes (
0.88, 95% CI −1.26, −0.51, p < 0.001); neutrophils ( −1.92, 95% CI
2.25, −1.60, p < 0.001); eosinophils ( −0.67, 95% CI −1.16, −0.18,
 = 0.007); immature granulocytes ( −1.82, 95% CI −2.60, −1.03,
 < 0.001) and thrombocytes ( −80.19, 95% CI −126.7, −33.7,
 = 0.001). EOPE was associated with increased NRBC count (
.20, 95% CI 0.57, 1.84, p < 0.001). After adjustment for gestational
ge and birth weight, EOPE remained associated with decreased
eutrophil count ( −0.92, 95% CI −1.27, −0.57, p < 0.001) and
ncreased NRBC count ( 1.11, 95% CI 0.27, 1.95, p = 0.010). The lin-
ar regression analyses did not reveal any signiﬁcant association
ith LOPE versus the (un)complicated control group.
. Discussion
In this study we observed that pregnancies complicated by EOPE
re associated with decreased leucocyte- (monocytes, neutrophils,
osinophils, immature granulocytes) and thrombocyte counts
nd with increased NRBC counts in umbilical cord blood. After
djustment for gestational age and birth weight, EOPE remained
ssociated with decreased neutrophil and increased NRBC counts.
Our ﬁndings demonstrate that the associations of most UCBC
ounts (total leucocytes, monocytes, eosinophils, immature gran-
locytes and thrombocytes) with EOPE are confounded byng Kruskall-Wallis testing and posthoc Mann-Whitney testing.
gestational age and birth weight, which is in agreement with pre-
vious studies (Davies et al., 1992; Proytcheva, 2009). It revealed
that LOPE compared to EOPE has a marginally impact on UCBC
populations, which may be explained by its milder phenotype as
well as the absence of FGR and PTB in this group. The 4–7-fold
decrease of neutrophil count and 5-fold increase of NRBC count in
association with EOPE however, were independent of gestational
age and birth weight. Because the innate immune-system matures
during pregnancy, this system of the newborn is prepared to be
fully functional at birth by a sudden neutrophil rise during the
late third trimester (Davies et al., 1992). The excessive oxidative
stress from early pregnancy onwards might have affected UCB neu-
trophil counts in EOPE by generating enhanced inﬂammation in the
fetal circulation, as demonstrated earlier by higher activated neu-
trophils and monocytes as well as increased CRP, -1-antitrypsin
and plasma chemokine levels (Catarino et al., 2012; Mellembakken
et al., 2001). As a consequence, fetal endothelial cell dysfunction
might occur, by which the maturation and development of fetal
haematopoiesis can be affected. Fetal haematopoiesis originates
from endothelial cells in the ventral aorta of the developing embryo
and is thus extremely sensitive to endothelial damage (Adamo and
Garcia-Cardena, 2012). It has been suggested that the maternal
endothelial cell damage is of more importance in EOPE than LOPE
and that the excessive oxidative stress develops only towards the
end of gestation in LOPE (Raymond and Peterson, 2011). This is
in line with the observed difference in leucocyte counts between
EOPE and LOPE. The association between PE and decreased UCB leu-
cocyte count has been described before and is in agreement with
our ﬁndings (Aali et al., 2007; Davies et al., 1992). Low neutrophil
counts might result in a temporarily reduced immune capacity of
the newborn, especially if the child is also born preterm. This might
increase the vulnerability for infections.
The observed increase of UCB NRBC in EOPE pregnancies is in
line with earlier studies (Aali et al., 2007; Akercan et al., 2005;
Catarino et al., 2009; Hebbar et al., 2014; Bayram et al., 2010).
However, Akercan- and Catarino et al. did not observe this increase
independent of gestational age, which can be explained by the lack
of separate analysis for EOPE and LOPE. High numbers of circulat-
ing NRBC can reﬂect an activation of erythropoiesis as a response
to the placental ischemia-reperfusion phenomenon resulting from
diminished and intermittent perfusion of the intervillous space or
a compensation of the erythrocyte-damage, both more profoundly
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Table  2
Linear regression analysis of UCBC count and differentials in EOPE and LOPE versus the (un)complicated control group (n = 195).
EOPE (n = 11) LOPE (n = 12)
Crude  Adjusted  (GA + BW)  Crude  Adjusted  (GA + BW)
Haemoglobin (mmol/L) −0.51 (−1.22, 0.21) 0.37 (−0.54, 1.29) 0.36 (−0.28, 1.01) 0.48 (−0.15, 1.12)
Haematocrit (L/L) 0.00 (−0.03, 0.04) 0.05* (0.00, 0.09) 0.02 (−0.01, 0.05) 0.03 (−0.01, 0.06)
Leucocytes
Total  leucocytes (x109/L) −7.6* (−10.53, −4.76) 0.32 (−3.14, 3.78) −0.75 (−3.66, 2.16) −0.07 (−2.68, 2.55)
Lymphocytes (109/L) −0.62 (−1.68, 0.44) 0.98 (−0.32, 2.28) −0.40 (−1.29, 0.50) −0.19 (−1.05, 0.66)
Monocytesa (109/L) −0.88* (−1.26, −0.51) −0.05 (−0.49, 0.39) −0.10 (−0.41, 0.22) −0.05 (−0.33, 0.23)
Granulocytes
Neutrophilsa (109/L) −1.92* (−2.25, −1.60) −0.92* (−1.27, −0.57) 0.05 (−0.22, 0.32) 0.14 (−0.08, 0.36)
Eosinophilsa (109/L) −0.67* (−1.16, −0.18) −0.37 (−1.01, 0.26) −0.08 (−0.49, 0.34) −0.10 (−0.51, 0.31)
Basophilsa (109/L) −0.51 (−1.12, 0.09) 0.59 (−0.15, 1.32) −0.05 (−0.56, 0.45) 0.04 (−0.44, 0.52)
Immature grana (109/L) −1.82* (−2.60, −1.03) −0.15 (−0.78, 1.07) −0.26 (−0.90, 0.37) −0.16 (−0.73, 0.41)
Erythroid cells
NRBCa (109/L) 1.20* (0.57, 1.84) 1.11* (0.27, 1.95) 0.07 (−0.54, 0.68) 0.08 (−0.53, 0.70)
Reticulocytes (x109/L) 18.93 (−9.72, 47.58) −24.25 (−60.40, 11.91) 1.12 (−25.36, 27.60) −5.34 (−30.48, 19.80)
Erythrocytes (x1012/L) −0.63* (−0.96, −0.30) 0.04 (−0.37, 0.44) 0.12 (−0.17, 0.42) 0.21 (−0.07, 0.49)
Thrombocytes
Thrombocytes (x109/L) −80.19* (−126.7, −33.7) −40.4 (−11.6, 19.8) −32.05 (−72.25, 8.16) −28.93 (−69.12, 11.27)
Data are presented as  (95% Conﬁdence Interval) with corresponding multivariable linear regression analysis of EOPE and LOPE versus the (un)complicated controls, crude
and  with adjustment for gestational age and birth weight. The regression coefﬁcient () indicates the increase or decrease (−) change per unit.
GA  gestational age; BW birth weight; NRBC nucleated red blood cells; UCBC umbilical cord blood cell; EOPE early- onset preeclampsia; LOPE late- onset preeclampsia; Immature
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a Log-transformed data.
* p < 0.05.
resent in EOPE than in LOPE (Aali et al., 2007; Catarino et al., 2009;
auniaux et al., 2006; Raymond and Peterson, 2011). The subop-
imal placental perfusion results in a relatively hypoxic placental
nvironment, which is beneﬁcial for early invasion of the cytotro-
hoblast into the maternal decidua. However a prolonged hypoxic
lacental state may  lead to an over-expression of hypoxia-inducible
actor 1 (HIF-1), regulating several processes such as erythro-
oiesis (Rath et al., 2016). Placental over-expression of HIF-1 has
een described in PE pregnancies, which may  explain our ﬁnding
f enhanced NRBC counts in umbilical cord blood, being a result
f HIF-1-induced erythropoietin-release (Rath et al., 2016; Sezer
t al., 2013).
.1. Strengths and limitations
A strength of the study is that we investigated associations
etween PE and UCBC counts and differentials in EOPE and LOPE
eparately, which revealed a much stronger association between
CBC counts and EOPE, and is relevant concerning the different
etiologies of both. Moreover, associations were investigated inde-
endent of gestational age and birth weight.
Pregnancies complicated by EOPE in our study population ended
ore often in a Caesarean section. This unfortunately resulted
n more missing blood samples (n = 25, 59.5%) compared to LOPE
n = 7, 26.9%, p = 0.009) due to the emergency of the Caesarean
ections. Because of the sample size we were not able to adjust
or many confounders and therefore inherent to an observational
tudy residual confounding cannot be excluded. The wide conﬁ-
ence intervals demonstrate that the sample size also resulted in a
imited power of the study. This implies that certain UCBC values
ith seemingly clinical relevant UCBC differences between groups
ight have failed to achieve statistical signiﬁcance because of lack
f power. Additionally, a selection bias due to the relatively high
ercentage of EOPE and LOPE pregnancies with missing data might
e present, but this is an often occurring problem in high-risk
atients where medical care is a priority. Another limitation of our
tudy is the tertiary university hospital-setting, in which uncom-
licated pregnancies presented with a relatively high percentageof concurrent comorbidity (40%), for which they were referred.
These patients were mostly included in the cohort study in the
ﬁrst trimester of pregnancy. Complicated PE, FGR and PTB preg-
nancies were more often included as late cohort inclusions after
the ﬁrst trimester. They presented with less additional comorbid-
ity, as visualised in Supplemental Fig. 1. Two neonates only in EOPE
and LOPE were complicated by FGR. Therefore, future studies may
address differences in UCBC populations in a subgroup of early- and
late-onset PE complicated by FGR.
5. Conclusion
Derangements of fetal haematopoiesis, in particular of
neutrophil- and NRBC counts, are associated with EOPE only. These
ﬁndings imply potential impact on the future health of offspring,
and that heterogeneity in UCBC should be considered as confounder
in epigenetic association studies examining EOPE. Further investi-
gation is needed to establish the potential impact for future health
of offspring.
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